Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!

Early Cancer Detection Posters of Interest for ASCO 2024!

Home
asco conference 2024
top posters on early cancer detection at asco 2024

Top Posters on Early Cancer Detection to Watch at ASCO 2024

Liquid biopsy continues to consolidate its role as a tool for diagnosing multiple cancers. We are not far from a world where all the cancer risks individuals’ face can be effectively addressed through a combination of dedicated and proven Multi-cancer Early Detection (MCED) and Single-cancer Early Detection (SCED) tests that can cover any remaining screening gaps.

The 2024 ASCO Annual Meeting will convene top experts to discuss the latest advancements in liquid biopsies, covering everything from discovery to clinical application. Attendees can look forward to sessions on the biology of circulating tumor cells, plasma biomarkers, and cutting-edge technologies. The program will also explore early cancer detection, minimal residual disease monitoring, tumor evolution, immunotherapy integration, and computational science's role in these advancements. This gathering promises to offer a comprehensive view of the future of cancer diagnostics and treatment, highlighting the transformative potential of liquid biopsies in oncology.

DelveInsight has curated a list of some important poster presentations on early cancer detection to be showcased at ASCO 2024. Don't miss this unparalleled opportunity to advance your knowledge and contribute to the future of cancer research and clinical practice!

Date	Time	Presentation Title	Abstract Number	Company	Location
Saturday, June 1, 2024	9:00 AM – 12:00 PM CDT	A novel liquid biopsy assay with an 88% detection rate of genomic alterations across CNS tumors	Abstract: 2077 \| Poster Bd: 376		Hall A
Saturday, June 1, 2024	9:00 AM – 12:00 PM CDT	Clinical validation of Northstar Select, a novel liquid biopsy assay for comprehensive genomic profiling of solid tumors	Abstract: 3072 \| Poster Bd: 217		Hall A
Saturday, June 1, 2024	9:00 AM – 12:00 PM CDT	Classification of HER2 status across multiple cancers using epigenomic profiles from a novel liquid biopsy assay	Abstract: 3047 \| Poster Bd: 192		Hall A
Saturday, June 1, 2024	9:00 AM – 12:00 PM CDT	Analytical validation of the Labcorp Plasma Complete test to enable precision oncology through solid tumor liquid biopsy comprehensive genomic profiling	Abstract: 3063 \| Poster Bd: 208	$C:\Users\Niyati\AppData\Local\Microsoft\Windows\INetCache\Content.MSO\CCE5B82C.tmp$	Hall A
Saturday, June 1, 2024	1:30 PM – 4:30 PM CDT	PREVECOL, a predictive model for early detection of colorectal cancer and precancerous lesions in liquid biopsy	Abstract: 3629 \| Poster Bd: 292		Hall A
Saturday, June 1, 2024	9:00 AM – 12:00 PM CDT	Multi-cancer early detection (MCED) test performance in cancer survivors.	Abstract: 1628 \| Poster Bd: 499		Hall A
Monday, June 3, 2024	9:00 AM – 12:00 PM CDT	Effect of multi-cancer early detection screening on late-stage cancers: A modeling study	Abstract: 11076 \| Poster Bd: 271		Hall A
Saturday, June 1, 2024	1:30 PM – 4:30 PM CDT	Independent blinded validation of a novel blood-based early pancreatic cancer detection test	Abstract: 4166\| Poster Bd: 146		Hall A
Sunday, June 2, 2024	9:00 AM – 12:00 PM CDT	Matched tissue and circulating tumor DNA (ctDNA) analysis in renal cell carcinoma (RCC): Results from a multimodal real-world database	Abstract: 4533\| Poster Bd: 228		Hall A
Monday, June 3, 2024	9:00 AM – 12:00 PM CDT	Evaluation of a novel extracellular vesicle (EV) based ovarian cancer (OC) screening test in asymptomatic postmenopausal women	Abstract: 5553\| Poster Bd: 424		Hall A
Saturday, June 1, 2024	9:00 AM – 12:00 PM	Diagnostic test use and time to cancer diagnosis in Medicare recipients	Abstract: 1622\| Poster Bd: 493		Hall A

Tags:

Executive Summary

The 2024 ASCO Annual Meeting will convene top experts to discuss the latest advancements in liquid biopsies, covering everything from discovery to clinical application.

Early Cancer Detection Posters of Interest for ASCO 2024!

Top Posters on Early Cancer Detection to Watch at ASCO 2024

Executive Summary

Recent Articles